Ursodeoxycholic Acid Tablets IP 300 mg (UrsoSet-300)

PRODUCT NAME: Ursodeoxycholic Acid Tablets 300 mg – UrsoSet-300

Dosage Form: Tablets

UrsoSet-300 is a pharmaceutical formulation containing Ursodeoxycholic Acid Tablets IP 300 mg. Ursodeoxycholic acid is a bile acid used in the management of certain liver and gallbladder conditions, depending on the patient’s diagnosis and medical requirements.

Ursodeoxycholic acid works by changing the composition of bile and reducing the cholesterol content of bile. In selected patients, it may help dissolve certain cholesterol gallstones. It is also prescribed for specific cholestatic liver conditions, including primary biliary cholangitis, under medical supervision.

These Ursodeoxycholic Acid Tablets are intended for patients who require treatment based on a healthcare professional’s assessment. The appropriate dose and duration depend on the condition being treated, body weight, medical history and response to therapy. Patients should follow their prescribed treatment schedule and attend recommended follow-up appointments.

UrsoSet-300 is presented in tablet form, with the packaging displaying a strength of 300 mg. Before starting treatment, patients should inform their doctor about existing liver or gallbladder problems, other medical conditions, pregnancy or breastfeeding, and any medicines they currently use. The tablets should not be taken for self-treatment of unexplained abdominal pain or suspected gallstones. Proper medical evaluation helps determine whether this medicine is appropriate for an individual patient’s condition.

Category: Brand:

Description

MORE DETAILS ABOUT PRODUCT

Ursodeoxycholic Acid Tablets 300 mg – UrsoSet-300

  • Primary Use: Treatment of selected liver and bile-related conditions as prescribed.

  • Strength: 300 mg per tablet, as indicated by the product name and packaging.

  • Bile Composition: Helps reduce cholesterol saturation in bile.

  • Gallstone Management: May help dissolve certain cholesterol gallstones in suitable patients.

  • Liver Condition Management: Used in specific cholestatic liver disorders, including primary biliary cholangitis.

  • Mode of Administration: Taken orally according to the prescribed directions.

  • Treatment Duration: Depends on the diagnosis and response to treatment.

  • Monitoring: Medical follow-up may include liver function tests and other investigations when indicated.